These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17136027)

  • 1. Vascular function in patients with end-stage renal disease and/or coronary artery disease: a cardiac magnetic resonance imaging study.
    Zimmerli LU; Mark PB; Steedman T; Foster JE; Berg GA; Dargie HJ; Jardine AG; Delles C; Dominiczak AF
    Kidney Int; 2007 Jan; 71(1):68-73. PubMed ID: 17136027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aortic stiffness and diastolic flow abnormalities in end-stage renal disease assessed by magnetic resonance imaging.
    Doyle A; Mark PB; Johnston N; Foster J; Connell JM; Dargie H; Jardine A; Padmanabhan N
    Nephron Clin Pract; 2008; 109(1):c1-8. PubMed ID: 18463420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction.
    Edwards NC; Ferro CJ; Townend JN; Steeds RP
    Heart; 2008 Aug; 94(8):1038-43. PubMed ID: 18308865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-dimensional magnetic resonance velocity mapping of blood flow patterns in the aorta in patients with atherosclerotic coronary artery disease compared to age-matched normal subjects.
    Bogren HG; Buonocore MH; Valente RJ
    J Magn Reson Imaging; 2004 Apr; 19(4):417-27. PubMed ID: 15065165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical approach to evaluate asymptomatic coronary artery disease in end-stage renal disease patients at the initiation of dialysis.
    Tanaka A; Sakakibara M; Asada H; Tanaka T; Ishii H; Murohara T
    Ther Apher Dial; 2014 Apr; 18(2):167-73. PubMed ID: 24720408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular stiffness is related to superoxide generation in the vessel wall.
    Delles C; Zimmerli LU; McGrane DJ; Koh-Tan CH; Pathi VL; McKay AJ; Steedman T; Dargie HJ; Hamilton CA; Dominiczak AF
    J Hypertens; 2008 May; 26(5):946-55. PubMed ID: 18398337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and risk stratification of coronary artery disease in end-stage renal disease.
    Hakeem A; Bhatti S; Chang SM
    JACC Cardiovasc Imaging; 2014 Jul; 7(7):715-28. PubMed ID: 25034921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of coronary artery calcification score (CACS) for the detection of coronary artery disease (CAD) in chronic dialysis patients.
    Fujimoto N; Iseki K; Tokuyama K; Tamashiro M; Takishita S
    Clin Chim Acta; 2006 May; 367(1-2):98-102. PubMed ID: 16413522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial adipose tissue and coronary artery calcification in diabetic and nondiabetic end-stage renal disease patients.
    Tonbul HZ; Turkmen K; Kayıkcıoglu H; Ozbek O; Kayrak M; Biyik Z
    Ren Fail; 2011; 33(8):770-5. PubMed ID: 21770856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central artery pulse pressure in end-stage renal disease: the roles of aortic diameter, aortic stiffness and wave reflection.
    Pannier B; Guérin AP; Marchais SJ; Safar ME; London GM
    Blood Purif; 2011; 31(1-3):107-12. PubMed ID: 21228577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease.
    Varma R; Garrick R; McClung J; Frishman WH
    Cardiol Rev; 2005; 13(2):98-107. PubMed ID: 15705261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Diabetes Mellitus on Vascular Biomarkers in Patients with End-Stage Renal Disease.
    Moon J; Lee CJ; Lee SH; Kang SM; Choi D; Yoo TH; Park S
    Yonsei Med J; 2017 Jan; 58(1):75-81. PubMed ID: 27873498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Cardiovascular Reserve in Chronic Kidney Failure: A Matched Cohort Study.
    Ting SM; Hamborg T; McGregor G; Oxborough D; Lim K; Koganti S; Aldridge N; Imray C; Bland R; Fletcher S; Krishnan NS; Higgins RM; Townend J; Banerjee P; Zehnder D
    Am J Kidney Dis; 2015 Aug; 66(2):274-84. PubMed ID: 25900597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced effects of cardiac extracorporeal shock wave therapy on angiogenesis and myocardial function recovery in patients with end-stage coronary artery and renal diseases.
    Sung PH; Fu M; Chiang HJ; Huang CR; Chu CH; Lee MS; Yip HK
    Biomed J; 2021 Dec; 44(6 Suppl 2):S201-S209. PubMed ID: 35300948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis.
    de Lemos JA; Hillis LD
    J Am Soc Nephrol; 1996 Oct; 7(10):2044-54. PubMed ID: 8915964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive assessment of coronary vasodilation using cardiovascular magnetic resonance in patients at high risk for coronary artery disease.
    Nguyen PK; Meyer C; Engvall J; Yang P; McConnell MV
    J Cardiovasc Magn Reson; 2008 May; 10(1):28. PubMed ID: 18513419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease.
    Pannier B; Guerin AP; Marchais SJ; Metivier F; Safar ME; London GM
    Kidney Int; 2000 Mar; 57(3):1091-9. PubMed ID: 10720961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitral valve repair for medically refractory functional mitral regurgitation in patients with end-stage renal disease and advanced heart failure.
    Kainuma S; Taniguchi K; Daimon T; Sakaguchi T; Funatsu T; Miyagawa S; Kondoh H; Takeda K; Shudo Y; Masai T; Ohishi M; Sawa Y
    Circulation; 2012 Sep; 126(11 Suppl 1):S205-13. PubMed ID: 22965985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism.
    Mitsnefes MM; Kimball TR; Kartal J; Witt SA; Glascock BJ; Khoury PR; Daniels SR
    J Am Soc Nephrol; 2005 Sep; 16(9):2796-803. PubMed ID: 16049067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.